IIM
MDGL icon

INTECH Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

INTECH Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,238
Closed -$2.22M – 2213
2026
Q1 		$2.22M Sell
4,238
-3,063
-42% -$1.46M 0.02% 655
2025
Q4 		$4.25M Buy
7,301
+631
+9% +$322K 0.04% 438
2025
Q3 		$3.06M Sell
6,670
-2,393
-26% -$893K 0.03% 562
2025
Q2 		$2.74M Sell
9,063
-721
-7% -$215K 0.03% 575
2025
Q1 		$3.24M Buy
9,784
+1,696
+21% +$557K 0.03% 487
2024
Q4 		$2.5M Buy
8,088
+2,056
+34% +$578K 0.02% 583
2024
Q3 		$1.28M Buy
+6,032
New +$1.54M 0.01% 673

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

INTECH Investment Management's MDGL Position: Q2 2026 in Review

INTECH Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 4,238 shares — an estimated $2.22M sold.

INTECH Investment Management first reported a position in MDGL in Q3 2024 and held it in 7 quarters. The position peaked at $4.25M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • INTECH Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 4,238 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.22M.
  • INTECH Investment Management first reported a position in Madrigal Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Madrigal Pharmaceuticals position peaked at $4.25M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.